Global Blood Therapeutics Inc. (GBT)

50.89
NASDAQ : Health Technology
Prev Close 49.51
Day Low/High 48.56 / 51.07
52 Wk Low/High 30.15 / 54.88
Avg Volume 700.40K
Exchange NASDAQ
Shares Outstanding 56.32M
Market Cap 2.79B
EPS -3.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

The Fed and Trump Are Both Wrong: Cramer's 'Mad Money' Recap (Tuesday 12/4/18)

The Fed and Trump Are Both Wrong: Cramer's 'Mad Money' Recap (Tuesday 12/4/18)

Markets looking for reassurance aren't getting any from the White House or the Federal Reserve, Jim Cramer says.

Guerbet To Showcase Ongoing Collaboration With IBM Watson And Advanced Digital Solutions At RSNA 2018

Guerbet To Showcase Ongoing Collaboration With IBM Watson And Advanced Digital Solutions At RSNA 2018

Key collaborations will offer expanded capabilities that reinforce commitment to safety, efficiency, and accuracy to help improve decision-making and patient care

Lifshitz & Miller LLP Announces Investigation Of Access National Corporation, Engility Holdings, Inc., Floor & Decor Holdings, Inc., Global Blood Therapeutics, Inc., Intrexon Corporation, Keryx Biopharmaceuticals, Inc., Nevada Gold & Casinos, Inc., And Sonic Corp.

Lifshitz & Miller LLP Announces Investigation Of Access National Corporation, Engility Holdings, Inc., Floor & Decor Holdings, Inc., Global Blood Therapeutics, Inc., Intrexon Corporation, Keryx Biopharmaceuticals, Inc., Nevada Gold & Casinos, Inc., And Sonic Corp.

NEW YORK, Nov. 1, 2018 /PRNewswire/ -- Access National Corporation (ANCX) Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the sale of ANCX to Union Bankshares Corporation for 0.

Interesting GBT Put And Call Options For June 2019

Interesting GBT Put And Call Options For June 2019

Investors in Global Blood Therapeutics Inc saw new options become available this week, for the June 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Global Blood Therapeutics, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Global Blood Therapeutics, Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Global Blood Therapeutics, Inc.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Global Blood Therapeutics, Inc. - GBT

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Global Blood Therapeutics, Inc. - GBT

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Global Blood Therapeutics, Inc.

Noteworthy Thursday Option Activity: GBT, CARA, COUP

Noteworthy Thursday Option Activity: GBT, CARA, COUP

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Global Blood Therapeutics Inc , where a total volume of 2,914 contracts has been traded thus far today, a contract volume which is representative of approximately 291,400 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 42% of GBT's average daily trading volume over the past month, of 693,765 shares.

3 Biotech Stocks Ready to Burn Up

3 Biotech Stocks Ready to Burn Up

Biotechs are known for wild tears. Investors, you'll want to consider these drug makers.

Fear of Missing Out Outweighs Fear of Trump Political Fallout

Fear of Missing Out Outweighs Fear of Trump Political Fallout

If the market wanted an excuse to sell off it had it.

Strength in Growth Names Is Giving the Market a More Upbeat Feel

Strength in Growth Names Is Giving the Market a More Upbeat Feel

Apple in particular is helping the bullish cause.

Heineken Stock Boosted By China Deal as Jefferies Downgrades

Heineken Stock Boosted By China Deal as Jefferies Downgrades

If there is any good news on trade the potential for more market upside is strong.

First Week Of GBT March 2019 Options Trading

First Week Of GBT March 2019 Options Trading

Investors in Global Blood Therapeutics Inc saw new options become available this week, for the March 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 233 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Play the Hemorrhage in Global Blood's Stock

Play the Hemorrhage in Global Blood's Stock

I see the $32.50 to $35 area as major support for GBT.

3 Killer Stocks Trading at Unfair Discounts

3 Killer Stocks Trading at Unfair Discounts

Hurry up as these stocks won't stay in the bargain bin for too long.

First Week Of August 17th Options Trading For Global Blood Therapeutics (GBT)

First Week Of August 17th Options Trading For Global Blood Therapeutics (GBT)

Investors in Global Blood Therapeutics Inc saw new options begin trading this week, for the August 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GBT options chain for the new August 17th contracts and identified one put and one call contract of particular interest.

Even Momentum Traders Should Study Stock Charts

Even Momentum Traders Should Study Stock Charts

You don't have to 'believe' in technical analysis to use it to set your exit and entry points.

Many Names on My Radar

Many Names on My Radar

There is no question that we are becoming extended and ripe for some profit taking.

Having Some Good Luck With Biotech Names

Having Some Good Luck With Biotech Names

Overall it is still a positive day but the action is sloppy.

Markets Make an Art of Unpredictability

Markets Make an Art of Unpredictability

Oil isn't the only reason stocks are higher.

Markets Confused by Trump's Upcoming Iran Decision

Markets Confused by Trump's Upcoming Iran Decision

No matter what happens with Iran, it is not going to be a major market positive.

Interesting GBT Put And Call Options For July 20th

Investors in Global Blood Therapeutics Inc saw new options become available today, for the July 20th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 87 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

GUERBET : 2017 Annual Results

GUERBET : 2017 Annual Results

5 Stocks That Are Showing Signs of Reversing

5 Stocks That Are Showing Signs of Reversing

These names are showing technical characteristics of either bullish or bearish reversal patterns over the past week.